204 related articles for article (PubMed ID: 28829664)
21. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
[TBL] [Abstract][Full Text] [Related]
22. Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story.
Halazun KJ; Najjar M; Abdelmessih RM; Samstein B; Griesemer AD; Guarrera JV; Kato T; Verna EC; Emond JC; Brown RS
Ann Surg; 2017 Mar; 265(3):557-564. PubMed ID: 27611615
[TBL] [Abstract][Full Text] [Related]
23. Predictors of tumor-free survival after liver transplant in patient with hepatocellular carcinoma.
Shamsaeefar A; Nikeghbalian S; Kazemi K; Gholami S; Motazedian N; Motazedian N; Fallahzadeh ME; Moini M; Gramizadeh B; Malekhosseini SA
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():139-44. PubMed ID: 25894143
[TBL] [Abstract][Full Text] [Related]
24. Rapid fibrosis and significant histologic recurrence of hepatitis C after liver transplant is associated with higher tumor recurrence rates in hepatocellular carcinomas associated with hepatitis C virus-related liver disease: a single center retrospective analysis.
Vasavada BB; Chan CL
Exp Clin Transplant; 2015 Feb; 13(1):46-50. PubMed ID: 25654412
[TBL] [Abstract][Full Text] [Related]
25. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality.
Brandman D; Biggins SW; Hameed B; Roberts JP; Terrault NA
Liver Int; 2012 Jan; 32(1):158-64. PubMed ID: 22098119
[TBL] [Abstract][Full Text] [Related]
26. Liver Transplant Outcomes in a Newly Started Program.
Sultanaliev T; Zhexembayev A; Mukazhanov A; Zharkymbekov B; Kuttymuratov G; Spatayev Z; Ibrayev B; Yesmembetov K; Ashimkhanova A; Asykbayev M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():120-2. PubMed ID: 26640930
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
28. Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation.
Kollmann D; Sapisochin G; Goldaracena N; Hansen BE; Rajakumar R; Selzner N; Bhat M; McCluskey S; Cattral MS; Greig PD; Lilly L; McGilvray ID; Ghanekar A; Grant DR; Selzner M
Liver Transpl; 2018 Jun; 24(6):779-789. PubMed ID: 29604237
[TBL] [Abstract][Full Text] [Related]
29. Donation after cardiac death in the hepatocellular carcinoma patient: Same indication?
Vining CC; Ecker BL; Abt PL; Olthoff KM
Liver Transpl; 2017 Oct; 23(S1):S27-S33. PubMed ID: 28846212
[No Abstract] [Full Text] [Related]
30. Liver Transplantation in Recipients With High Model for End-stage Liver Disease Score.
González Martínez S; Molina Raya A; Becerra Massare A; Muffak Granero K; Villegas Herrera T; Villar Del Moral JM; Fundora Suárez Y
Transplant Proc; 2018 Mar; 50(2):595-597. PubMed ID: 29579862
[TBL] [Abstract][Full Text] [Related]
31. Prognostic evaluation of patients undergoing living-donor liver transplant by APACHE II and MELD scores.
Zhang ZY; Chen R; Zhou ZQ; Peng CH; Zhou GW
Exp Clin Transplant; 2015 Feb; 13(1):41-5. PubMed ID: 24779711
[TBL] [Abstract][Full Text] [Related]
32. Effect of pretransplant diabetes on short-term outcomes after liver transplantation: a national cohort study.
Hoehn RS; Singhal A; Wima K; Sutton JM; Paterno F; Steve Woodle E; Hohmann S; Abbott DE; Shah SA
Liver Int; 2015 Jul; 35(7):1902-9. PubMed ID: 25533420
[TBL] [Abstract][Full Text] [Related]
33. Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
Cepeda-Franco C; Bernal-Bellido C; Barrera-Pulido L; Álamo-Martínez JM; Ruiz-Matas JH; Suárez-Artacho G; Marín-Gómez LM; Tinoco-González J; Díaz-Aunión C; Padillo-Ruiz FJ; Gómez-Bravo MÁ
Transplant Proc; 2016 Nov; 48(9):2983-2986. PubMed ID: 27932125
[TBL] [Abstract][Full Text] [Related]
34. Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts.
Croome KP; Wall W; Chandok N; Beck G; Marotta P; Hernandez-Alejandro R
Liver Transpl; 2013 Nov; 19(11):1214-23. PubMed ID: 23907778
[TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
[TBL] [Abstract][Full Text] [Related]
36. Rescue management of early complications after liver transplantation-key for the long-term success.
Andrassy J; Wolf S; Hoffmann V; Rentsch M; Stangl M; Thomas M; Pratschke S; Frey L; Gerbes A; Meiser B; Angele M; Werner J; Guba M
Langenbecks Arch Surg; 2016 May; 401(3):389-96. PubMed ID: 26960592
[TBL] [Abstract][Full Text] [Related]
37. The impact of treated bacterial infections within one month before living donor liver transplantation in adults.
Hara T; Soyama A; Takatsuki M; Hidaka M; Carpenter I; Kinoshita A; Adachi T; Kitasato A; Kuroki T; Eguchi S
Ann Transplant; 2014 Dec; 19():674-9. PubMed ID: 25536330
[TBL] [Abstract][Full Text] [Related]
38. Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection.
Court CM; Harlander-Locke MP; Markovic D; French SW; Naini BV; Lu DS; Raman SS; Kaldas FM; Zarrinpar A; Farmer DG; Finn RS; Sadeghi S; Tomlinson JS; Busuttil RW; Agopian VG
Liver Transpl; 2017 Sep; 23(9):1123-1132. PubMed ID: 28688158
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.
Berry K; Ioannou GN
Gastroenterology; 2015 Sep; 149(3):669-80; quiz e15-6. PubMed ID: 26021233
[TBL] [Abstract][Full Text] [Related]
40. Management of recurrent hepatitis C virus after liver transplantation.
Jiménez-Pérez M; González-Grande R; Rando-Muñoz FJ
World J Gastroenterol; 2014 Nov; 20(44):16409-17. PubMed ID: 25469009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
